Item Type | Name |
Academic Article
|
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
|
Academic Article
|
Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.
|
Academic Article
|
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
|
Academic Article
|
Relaxin/RXFP1 signaling in prostate cancer progression.
|
Academic Article
|
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.
|
Academic Article
|
Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors.
|
Academic Article
|
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
|
Academic Article
|
Platelets increase the proliferation of ovarian cancer cells.
|
Concept
|
Sequence Analysis, RNA
|
Concept
|
RNA Processing, Post-Transcriptional
|
Concept
|
DEAD-box RNA Helicases
|
Concept
|
RNA
|
Concept
|
RNA, Small Interfering
|
Concept
|
RNA, Ribosomal
|
Concept
|
RNA-Induced Silencing Complex
|
Concept
|
RNA Polymerase II
|
Concept
|
RNA Interference
|
Concept
|
RNA Editing
|
Concept
|
RNA, Untranslated
|
Concept
|
RNA-Binding Proteins
|
Concept
|
RNA Stability
|
Concept
|
RNA, Neoplasm
|
Concept
|
RNA Splice Sites
|
Concept
|
RNA, Messenger
|
Academic Article
|
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
|
Academic Article
|
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.
|
Academic Article
|
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
|
Academic Article
|
Integrated genomic analyses of ovarian carcinoma.
|
Academic Article
|
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
|
Academic Article
|
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
|
Academic Article
|
The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression.
|
Academic Article
|
Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.
|
Academic Article
|
Dual targeting of EphA2 and FAK in ovarian carcinoma.
|
Academic Article
|
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation.
|
Academic Article
|
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
|
Academic Article
|
p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.
|
Academic Article
|
Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.
|
Academic Article
|
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.
|
Academic Article
|
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
|
Academic Article
|
The dicey role of Dicer: implications for RNAi therapy.
|
Academic Article
|
Sustained small interfering RNA delivery by mesoporous silicon particles.
|
Academic Article
|
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma.
|
Academic Article
|
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
|
Academic Article
|
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
|
Academic Article
|
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
|
Academic Article
|
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
|
Academic Article
|
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
|
Academic Article
|
A new method for stranded whole transcriptome RNA-seq.
|
Academic Article
|
ATP11B mediates platinum resistance in ovarian cancer.
|
Academic Article
|
A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation.
|
Academic Article
|
Hematogenous metastasis of ovarian cancer: rethinking mode of spread.
|
Academic Article
|
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
|
Academic Article
|
Strategies for in vivo siRNA delivery in cancer.
|
Academic Article
|
Estrous cycle modulates ovarian carcinoma growth.
|
Academic Article
|
Liposomal siRNA for ovarian cancer.
|
Academic Article
|
Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.
|
Academic Article
|
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.
|
Academic Article
|
Nanomedicine based approaches for the delivery of siRNA in cancer.
|
Academic Article
|
Computational identification of gene-social environment interaction at the human IL6 locus.
|
Academic Article
|
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
|
Academic Article
|
RNA interference in the clinic: challenges and future directions.
|
Academic Article
|
Functional roles of Src and Fgr in ovarian carcinoma.
|
Academic Article
|
Chitosan hydrogel for localized gene silencing.
|
Academic Article
|
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.
|
Academic Article
|
N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl- cotransporter-2 impairs spinal chloride homeostasis in neuropathic pain.
|
Academic Article
|
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
|
Academic Article
|
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.
|
Academic Article
|
Poor survival with wild-type TP53 ovarian cancer?
|
Academic Article
|
API5 confers tumoral immune escape through FGF2-dependent cell survival pathway.
|
Academic Article
|
Genomic instability is associated with lack of telomerase activation in ovarian cancer.
|
Academic Article
|
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.
|
Academic Article
|
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
|
Academic Article
|
Dicer, Drosha, and outcomes in patients with ovarian cancer.
|
Academic Article
|
SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.
|
Academic Article
|
Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
|
Academic Article
|
Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
|
Academic Article
|
Liposomal siRNA nanocarriers for cancer therapy.
|
Academic Article
|
Notch3 pathway alterations in ovarian cancer.
|
Academic Article
|
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
|
Academic Article
|
Targeted gene silencing using RGD-labeled chitosan nanoparticles.
|
Academic Article
|
Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
|
Academic Article
|
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.
|
Academic Article
|
TP53 loss creates therapeutic vulnerability in?colorectal cancer.
|
Academic Article
|
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.
|
Academic Article
|
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.
|
Academic Article
|
MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
|
Academic Article
|
Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.
|
Academic Article
|
Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer.
|
Academic Article
|
RNAi therapies: drugging the undruggable.
|
Academic Article
|
Convergence of nanotechnology and cancer prevention: are we there yet?
|
Academic Article
|
The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression.
|
Academic Article
|
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
|
Academic Article
|
Therapeutic silencing of KRAS using systemically delivered siRNAs.
|
Academic Article
|
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.
|
Academic Article
|
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.
|
Academic Article
|
Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
|
Academic Article
|
Preclinical and clinical development of siRNA-based therapeutics.
|
Academic Article
|
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
|
Academic Article
|
XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.
|
Academic Article
|
Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
|
Academic Article
|
Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
|
Academic Article
|
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
|
Academic Article
|
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
|
Academic Article
|
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.
|
Academic Article
|
Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray.
|
Academic Article
|
Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
|
Academic Article
|
?Np63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.
|
Academic Article
|
A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets.
|
Academic Article
|
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis
|
Academic Article
|
RNA-targeted therapeutics in cancer clinical trials
|
Academic Article
|
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
|
Academic Article
|
Profiling long noncoding RNA expression using custom-designed microarray
|
Academic Article
|
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
|
Academic Article
|
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
|
Academic Article
|
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.
|
Academic Article
|
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.
|
Academic Article
|
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway.
|
Academic Article
|
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.
|
Academic Article
|
Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2.
|
Academic Article
|
Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition.
|
Academic Article
|
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
|
Academic Article
|
Evoking picomolar binding in RNA by a single phosphorodithioate linkage.
|
Academic Article
|
RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.
|
Academic Article
|
microRNA Therapeutics in Cancer - An Emerging Concept.
|
Academic Article
|
Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).
|
Academic Article
|
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
|
Academic Article
|
MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.
|
Academic Article
|
HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer.
|
Academic Article
|
Role of Platelet-Derived Tgf?1 in the Progression of Ovarian Cancer.
|
Academic Article
|
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer.
|
Academic Article
|
Chitosan Nanoparticles for miRNA Delivery.
|
Academic Article
|
The role of long noncoding RNAs in cancer: the dark matter matters.
|
Academic Article
|
MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels.
|
Academic Article
|
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.
|
Academic Article
|
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
|
Academic Article
|
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
|
Academic Article
|
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
|
Academic Article
|
Isolation of Extracellular RNA from Serum/Plasma.
|
Academic Article
|
Association of biobehavioral factors with non-coding RNAs in cervical cancer.
|
Academic Article
|
Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer.
|
Academic Article
|
Activating Transcription Factor 4 Modulates TGF?-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.
|
Academic Article
|
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
|
Academic Article
|
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
|
Academic Article
|
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
|
Academic Article
|
Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for Cancer.
|
Academic Article
|
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
|
Academic Article
|
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.
|
Academic Article
|
RNA interference-based therapy and its delivery systems.
|
Academic Article
|
Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis.
|
Academic Article
|
Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation.
|
Academic Article
|
exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids.
|
Concept
|
RNA, Long Noncoding
|
Academic Article
|
Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy.
|
Academic Article
|
Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.
|
Academic Article
|
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
|
Academic Article
|
Clinical and biological significance of EZH2 expression in endometrial cancer.
|
Academic Article
|
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.
|
Academic Article
|
Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.
|
Academic Article
|
GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
|
Academic Article
|
Role of Micro-RNA for Pain After Surgery: Narrative Review of Animal and Human Studies.
|
Academic Article
|
PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.
|
Academic Article
|
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity.
|
Academic Article
|
Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
|
Academic Article
|
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site.
|
Academic Article
|
Phase 2 of extracellular RNA communication consortium charts next-generation approaches for extracellular RNA research.
|
Academic Article
|
Biobehavioral factors predict an exosome biomarker of ovarian carcinoma disease progression.
|
Academic Article
|
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors.
|
Academic Article
|
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site.
|
Academic Article
|
Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins.
|